Business Standard

AstraZeneca Pharma gains ahead of board meet for 'Strategy Plan'

A special meeting of the board of directors of the company will be held today, to consider the 'Strategy Plan' for the company.

Related News

India has rallied 6% to Rs 843 in early noon deals on BSE ahead of its board meeting today to consider a “Strategy Plan” for the company.

“A special meeting of the board of directors of the company will be held on May 06, to consider the 'Strategy Plan' for the company,” AstraZeneca Pharma India said in a regulatory filing.

On March 5, the company informed the exchanges that the promoter shareholder of the company — AstraZeneca Pharmaceuticals AB Sweden — had notified its decision to reduce its shareholding in the company in order to comply with the requirement of minimum public shareholding norms.

As per the norms stipulated by Sebi, privately promoted companies are expected to have public shareholding at 25% by June 2013.

As of March 31, the promoters held a 90% stake in the company. FIIs held 0.01% stake, while the remaining holdings are with non institutional investors and bodies corporate.

Meanwhile, the stock has rallied 13.3% in past two trading sessions compared to 0.54% fall in benchmark Sensex, after the pharmaceutical company said its net losses almost halved to Rs 18.58 crore for the quarter ended March 2013 due to lower staff cost. The company had loss of Rs 33.01 crore in a year ago quarter.

The stock opened at Rs 810 and hit a high of Rs 849 on NSE. A combined around 187,000 shares changed hands on the counter till 1119 hours on NSE and BSE.
 

Read more on:   
|
|

AstraZeneca Pharma gains ahead of board meet for 'Strategy Plan'

A special meeting of the board of directors of the company will be held today, to consider the 'Strategy Plan' for the company.

A special meeting of the board of directors of the company will be held today, to consider the 'Strategy Plan' for the company.
India has rallied 6% to Rs 843 in early noon deals on BSE ahead of its board meeting today to consider a “Strategy Plan” for the company.

“A special meeting of the board of directors of the company will be held on May 06, to consider the 'Strategy Plan' for the company,” AstraZeneca Pharma India said in a regulatory filing.

On March 5, the company informed the exchanges that the promoter shareholder of the company — AstraZeneca Pharmaceuticals AB Sweden — had notified its decision to reduce its shareholding in the company in order to comply with the requirement of minimum public shareholding norms.

As per the norms stipulated by Sebi, privately promoted companies are expected to have public shareholding at 25% by June 2013.

As of March 31, the promoters held a 90% stake in the company. FIIs held 0.01% stake, while the remaining holdings are with non institutional investors and bodies corporate.

Meanwhile, the stock has rallied 13.3% in past two trading sessions compared to 0.54% fall in benchmark Sensex, after the pharmaceutical company said its net losses almost halved to Rs 18.58 crore for the quarter ended March 2013 due to lower staff cost. The company had loss of Rs 33.01 crore in a year ago quarter.

The stock opened at Rs 810 and hit a high of Rs 849 on NSE. A combined around 187,000 shares changed hands on the counter till 1119 hours on NSE and BSE.
 
image

Read More

Metal shares rises as LMEX surges 5%

Hindalco Industries, Sterlite Industries, Tata Steel, Sesa Goa, NMDC and Hindustan Zinc are up 2-4% on BSE.

Recommended for you

Advertisements

Quick Links

Market News

Sensex ends above 27,900 amid volatile session

Provisionally, the Sensex gained 134.71 points to end at 27,944.06 and the Nifty rose 27.80 points to close at 8,448.80

Sangam (India) zooms over 50% in four days on stake hike by promoter

The stock is currently trading at its record high of Rs 125 and has rallied 54% from Rs 81 on May 19.

Sagar Cements surges after turnaround in Q4

The stock surged 16% to Rs 408 after reported net profit of Rs 21.70 crore in March quarter against loss of Rs 11.36 crore in the year ago ...

SBI pares early gains post Q4 results

The stock surged 5% to Rs 305 after reported 23% year on year jump in standalone net profit at Rs 3,742 crore in March quarter.

Markets hold gains amid firm global cues

Sensex has soared 214 points to trade at 28,023 levels while the Nifty has surged 55 points to quote at 8,476 mark

 

Back to Top